Tag «EBIO»

Investor’s Roundup (Risk Factors in Focus) – Eleven Biotherapeutics Inc (NASDAQ: EBIO)

U.S. stocks logged sharp gains Friday, with major indexes shaking off an early slide as technology stocks—notably Apple Inc.—rallied, overshadowing uncertainty over tense trade talks between the U.S. and China and a weaker-than-predictable rise in April nonfarm payrolls. The Dow Jones Industrial Average rose 332.36 points, or 1.39%, to end at 24,262.51, recovering from an …

Is The Stock Risky? (Beta Analysis) – Eleven Biotherapeutics Inc (NASDAQ: EBIO)

Major indices in the Asia-Pacific regions were all slightly higher in early trade Thursday morning, while U.S. stock futures also traded in the green overnight. In Tokyo, the benchmark Nikkei 225 was up 0.46% to 21,349.58; Hong Kong’s Hang Seng index was 1.44% higher at 30,631.13. Stocks in Shanghai were 0.25% higher, and stocks also …

An Eye on Beta – Eleven Biotherapeutics Inc (NASDAQ: EBIO)

U.S. stocks meandered but finished mostly higher Tuesday as retailers and industrial companies rose, and a jump in metals prices helped mining and materials companies. Asian markets jumped after the North Korean government said it was open to talks with the U.S. about ending its nuclear program. On Tuesday: The Standard & Poor’s 500 index …